RE: Undervalued15 Mar 2017 11:34
Copy all that mate - BTW, I don't think I've seen anyone mention it (surprise) as people have been banging on about the invoiced sales vs delayed revenue model here (not rocket science to me but hey ......) but they booked +19% REVENUE increase in H2 vs flat in H1 which demonstrates that the +25% increased invoiced sales earlier in the year fed through into actual cash in the second half.
Now factor in the huge increase in invoiced sales in H2 and project that into the current H1 revenue ahead of interim results in September - it ain't bleeding rocket science ...
We had the same thing with delayed cash with SLP's basket price - we could all see the cash was starting to pour in but it was delayed by three months but eventually it was reflected in the SP and it bagged and is still looking great now.
Depending on how you choose to look at it (regardless of what some new arrivals may *say* on here ......) this is shaping up very nicely imo at this level of SP and for all we know, H1 2017 invoiced numbers could blow H2 2016 invoiced numbers out of the water again if they've got the big momentum in a growing market sector that they could could, quite viably, become world leaders in ...